KR20010020423A - 결정형 마크로리드 및 이들의 제조방법 - Google Patents
결정형 마크로리드 및 이들의 제조방법 Download PDFInfo
- Publication number
- KR20010020423A KR20010020423A KR1019997010048A KR19997010048A KR20010020423A KR 20010020423 A KR20010020423 A KR 20010020423A KR 1019997010048 A KR1019997010048 A KR 1019997010048A KR 19997010048 A KR19997010048 A KR 19997010048A KR 20010020423 A KR20010020423 A KR 20010020423A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- preparation
- crystalline
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
- 결정형의 화학식 (I)의 화합물 또는 그의 호변이성체 또는 용매화된 형태.<화학식 I>
- 제1항에 있어서, A 형 결정인 화합물.
- 제1항에 있어서, B 형 결정인 화합물.
- 무정형 화학식 (I)의 화합물을 그의 용액으로부터 결정화-유발 조건 하에서 적절히 전환시키는 것을 포함하는 제1항에 따른 화합물의 제조 방법.
- A 형 이외의 화학식 (I)의 화합물, 그의 호변이성체 또는 용매화된 형태를 그의 용액으로부터 A 형의 선별적 결정화를 포함하는 조건하에서 적절히 전환시키는 것을 포함하는 제2항에 따른 화합물의 제조를 위한 제4항에 따른 제법의 별법.
- B 형 이외의 화학식 (I)의 화합물, 그의 호변이성체 또는 용매화된 형태를 그의 용액으로부터 B 형의 선별적 결정화를 포함하는 조건하에서 적절히 전환시키는 것을 포함하는 제3항에 따른 화합물의 제조를 위한 제4항에 따른 제법의 별법.
- 제1항 내지 3항 내지 어느 한 항에 따른 화합물로부터 제조된 것이면 무엇이든지 포함하는 제약 조성물.
- 의약으로써 또는 의약의 제조에 사용하기 위한 제1항 내지 3항 중 어느 한 항에 다른 화합물.
- 제4항 내지 6항 중 어느 한 항에 따른 방법에 의해 제조된 것이면 무었이든지, 제1항 내지 제3항 중 어느 한 항에 따른 화합물.
- 제1항에 따른 결정형으로부터 제조된 것이면 무었이든지, 제1항에 기재한 화학식 (I)의 화합물, 그의 비결정형 상태, 또는 호변이성체 또는 용매화된 형태.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9713730.1A GB9713730D0 (en) | 1997-06-30 | 1997-06-30 | Organic compounds |
GB9713730.1 | 1997-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010020423A true KR20010020423A (ko) | 2001-03-15 |
KR100399765B1 KR100399765B1 (ko) | 2003-09-29 |
Family
ID=10815103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-1999-7010048A KR100399765B1 (ko) | 1997-06-30 | 1998-06-26 | 결정형 마크로리드 및 이들의 제조방법 |
Country Status (32)
Country | Link |
---|---|
US (1) | US6423722B1 (ko) |
EP (1) | EP0994880B1 (ko) |
JP (2) | JP3880634B2 (ko) |
KR (1) | KR100399765B1 (ko) |
CN (1) | CN1139595C (ko) |
AR (1) | AR017754A1 (ko) |
AT (1) | ATE287410T1 (ko) |
AU (1) | AU739211B2 (ko) |
BR (1) | BR9810956A (ko) |
CA (1) | CA2290412C (ko) |
CO (1) | CO4940463A1 (ko) |
CZ (1) | CZ297244B6 (ko) |
DE (1) | DE69828692T2 (ko) |
DK (1) | DK0994880T3 (ko) |
ES (1) | ES2236922T3 (ko) |
GB (1) | GB9713730D0 (ko) |
HK (1) | HK1028597A1 (ko) |
HU (1) | HU227755B1 (ko) |
ID (1) | ID24897A (ko) |
IL (1) | IL132761A0 (ko) |
MY (1) | MY118718A (ko) |
NO (1) | NO312765B1 (ko) |
NZ (1) | NZ500994A (ko) |
PE (1) | PE97699A1 (ko) |
PL (1) | PL192761B1 (ko) |
PT (1) | PT994880E (ko) |
RU (1) | RU2219181C2 (ko) |
SK (1) | SK285665B6 (ko) |
TR (1) | TR199903189T2 (ko) |
TW (1) | TW552264B (ko) |
WO (1) | WO1999001458A1 (ko) |
ZA (1) | ZA985655B (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
GB0125443D0 (en) * | 2001-10-23 | 2001-12-12 | Novartis Ag | Organic Compounds |
DE602004024417D1 (de) * | 2003-09-03 | 2010-01-14 | Glaxo Group Ltd | Neues verfahren zur herstellung von pleuromutilinderivaten |
KR20070060144A (ko) * | 2004-12-01 | 2007-06-12 | 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 | 결정체 마크로라이드의 제조 방법 |
WO2008057511A2 (en) * | 2006-11-06 | 2008-05-15 | Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
US20100105724A1 (en) * | 2006-12-07 | 2010-04-29 | Helsinn Healthcare Sa | Crystalline and amorphous forms of palonosetron hydrochloride |
US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
JP2012532670A (ja) | 2009-07-10 | 2012-12-20 | ボストン サイエンティフィック サイムド,インコーポレイテッド | 薬剤搬送バルーンのためのナノ結晶の使用 |
EP2453938B1 (en) | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
WO2012031236A1 (en) | 2010-09-02 | 2012-03-08 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
WO2013022458A1 (en) * | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
US9056152B2 (en) | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
CN105102967B (zh) | 2013-03-15 | 2018-10-12 | 生物传感器国际集团有限公司 | 雷帕霉素衍生物的纯化 |
EP3178824A1 (en) | 2015-12-08 | 2017-06-14 | Medichem, S.A. | Process for preparing pimecrolimus |
EP3619215B1 (en) * | 2017-05-01 | 2021-11-17 | MEDA Pharma GmbH & Co. KG | Process to convert crude ascomycin into purified pimecrolimus |
EP3741367A1 (en) | 2019-05-21 | 2020-11-25 | Premark Pharma GmbH | Treatment of ocular disease |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51118816A (en) * | 1975-04-08 | 1976-10-19 | Meiji Seika Kaisha Ltd | A process for stabilizing non-crystalloidal solid |
US4127647A (en) * | 1975-04-08 | 1978-11-28 | Meiji Seika Kaisha, Ltd. | Process for preparation of stable amorphous macrolide antibiotic solids |
CY1306A (en) | 1980-10-01 | 1985-12-06 | Glaxo Group Ltd | Aminoalkyl furan derivative |
JP2728482B2 (ja) * | 1989-01-26 | 1998-03-18 | 協和醗酵工業株式会社 | マクロライド系抗生物質の精製法 |
EP0433428B1 (en) | 1989-07-10 | 1994-10-12 | Chemferm V.O.F. | A stable form of cephradine, process for its production and intermediates used therein |
AU640963B2 (en) * | 1989-11-09 | 1993-09-09 | MEDA Pharma S.a.r.l | Heteroatoms-containing tricyclic compounds |
IE910847A1 (en) * | 1990-03-13 | 1991-09-25 | Fisons Plc | Immunosuppressive macrocyclic compounds |
EP0480623A1 (en) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | New halomacrolides and derivatives having immunosuppressive activity |
US5143918A (en) * | 1990-10-11 | 1992-09-01 | Merck & Co., Inc. | Halomacrolides and derivatives having immunosuppressive activity |
DE69217762T2 (de) | 1991-07-30 | 1997-10-09 | Ajinomoto Kk | Kristalle von N-(Trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung |
US5247076A (en) | 1991-09-09 | 1993-09-21 | Merck & Co., Inc. | Imidazolidyl macrolides having immunosuppressive activity |
US5221740A (en) | 1992-01-16 | 1993-06-22 | American Home Products Corporation | Oxepane isomers of rapamycin useful as immunosuppressive agents |
UA41884C2 (uk) * | 1993-11-05 | 2001-10-15 | Амерікан Хоум Продактс Корпорейшн | Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів |
JP3808500B2 (ja) * | 1994-02-22 | 2006-08-09 | キューレータズ オブ ディ ユニバーシティ オブ ミズーリ | 分離剤としての大環状抗生物質 |
JPH11512096A (ja) * | 1995-08-24 | 1999-10-19 | メルク エンド カンパニー インコーポレーテッド | イミダゾリルマクロライド免疫抑制剤の製造方法 |
GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
-
1997
- 1997-06-30 GB GBGB9713730.1A patent/GB9713730D0/en active Pending
-
1998
- 1998-06-25 CO CO98036359A patent/CO4940463A1/es unknown
- 1998-06-26 IL IL13276198A patent/IL132761A0/xx not_active IP Right Cessation
- 1998-06-26 SK SK1866-99A patent/SK285665B6/sk not_active IP Right Cessation
- 1998-06-26 CZ CZ0474099A patent/CZ297244B6/cs not_active IP Right Cessation
- 1998-06-26 HU HU0003053A patent/HU227755B1/hu unknown
- 1998-06-26 PT PT98936392T patent/PT994880E/pt unknown
- 1998-06-26 NZ NZ500994A patent/NZ500994A/en not_active IP Right Cessation
- 1998-06-26 BR BR9810956-1A patent/BR9810956A/pt not_active Application Discontinuation
- 1998-06-26 TR TR1999/03189T patent/TR199903189T2/xx unknown
- 1998-06-26 RU RU2000101826/04A patent/RU2219181C2/ru active
- 1998-06-26 WO PCT/EP1998/003929 patent/WO1999001458A1/en active IP Right Grant
- 1998-06-26 CN CNB988064677A patent/CN1139595C/zh not_active Expired - Lifetime
- 1998-06-26 AR ARP980103094A patent/AR017754A1/es active IP Right Grant
- 1998-06-26 KR KR10-1999-7010048A patent/KR100399765B1/ko not_active IP Right Cessation
- 1998-06-26 AU AU85409/98A patent/AU739211B2/en not_active Expired
- 1998-06-26 ES ES98936392T patent/ES2236922T3/es not_active Expired - Lifetime
- 1998-06-26 ID IDW991682A patent/ID24897A/id unknown
- 1998-06-26 PE PE1998000568A patent/PE97699A1/es not_active IP Right Cessation
- 1998-06-26 DK DK98936392T patent/DK0994880T3/da active
- 1998-06-26 JP JP50628799A patent/JP3880634B2/ja not_active Expired - Lifetime
- 1998-06-26 AT AT98936392T patent/ATE287410T1/de active
- 1998-06-26 DE DE69828692T patent/DE69828692T2/de not_active Expired - Lifetime
- 1998-06-26 CA CA002290412A patent/CA2290412C/en not_active Expired - Lifetime
- 1998-06-26 PL PL336719A patent/PL192761B1/pl unknown
- 1998-06-26 EP EP98936392A patent/EP0994880B1/en not_active Expired - Lifetime
- 1998-06-29 ZA ZA985655A patent/ZA985655B/xx unknown
- 1998-06-29 MY MYPI98002955A patent/MY118718A/en unknown
- 1998-07-21 TW TW087111867A patent/TW552264B/zh not_active IP Right Cessation
-
1999
- 1999-12-02 NO NO19995909A patent/NO312765B1/no not_active IP Right Cessation
-
2000
- 2000-10-17 US US09/690,404 patent/US6423722B1/en not_active Expired - Lifetime
- 2000-10-25 HK HK00106806A patent/HK1028597A1/xx not_active IP Right Cessation
-
2006
- 2006-03-01 JP JP2006055107A patent/JP4504323B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4504323B2 (ja) | 結晶性マクロライドおよびその調製方法 | |
EP4073036B1 (en) | Crystalline form of a 7h-benzo[7]annulene-2-carboxylic acid derivative | |
JP2023532787A (ja) | 結晶形態のウパダシチニブ(upadacitinib)、その調製方法及びその使用 | |
Maruyama et al. | Mechanism of the solvent-mediated transformation of taltirelin polymorphs promoted by methanol | |
Caplette et al. | Characterization of new crystalline forms of hydroxyprogesterone caproate | |
AU2004238833A1 (en) | Polymorphs of cabergoline | |
JP4655930B2 (ja) | キノリンカルボン酸誘導体溶媒和物の結晶 | |
MXPA99011294A (es) | Macrolidos cristalinos y proceso para su preparacion | |
MXPA04010284A (es) | Polimorfo de derivado de ascomicina. | |
IL263908B (en) | Method for preparing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl)-n-cyclopropyl-4-methylbenzamide | |
EP2462154B1 (en) | Novel crystal form of cdb-4124 and process for the preparation thereof | |
RU2792728C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФНОЙ ФОРМЫ 3-[5-АМИНО-4-(3-ЦИАНОБЕНЗОИЛ)ПИРАЗОЛ-1-ил]-N-ЦИКЛОПРОПИЛ-4-МЕТИЛБЕНЗАМИДА | |
CN107868117B (zh) | 司坦唑醇糖精盐及其制备方法和应用 | |
RU2765719C2 (ru) | Способ получения полиморфной формы 3-[5-амино-4-(3-цианобензоил)пиразол-1-ил]-n-циклопропил-4-метилбензамида | |
WO2023137035A1 (en) | Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide | |
WO2005122698A2 (en) | Novel stable polymorphic forms of tiagabine hydrochloride | |
EA044645B1 (ru) | Способ получения апиксабана | |
US20080249035A1 (en) | Polymorph of Clarithromycin (Form V) | |
MX2007003719A (en) | Tadalafil crystal forms and processes for preparing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120910 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20130905 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140904 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20150903 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20160908 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20170807 Year of fee payment: 15 |
|
EXPY | Expiration of term |